Year: 2024

Brazil Potash Announces Pricing of Initial Public Offering

Written by Customer Service on November 27, 2024. Posted in Public Companies.

MANAUS, Brazil, Nov. 26, 2024 (GLOBE NEWSWIRE) — Brazil Potash Corp. (“Brazil Potash” or the “Company”) announced today the pricing of its initial public offering (the “IPO”) of 2,000,000 of its common shares, no par value per share (“Common Shares”), at a price to the public of $15.00 per share. All of the Common Shares are being offered by the Company. The gross proceeds to the Company from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, are expected to be approximately $30.0 million. In addition, the Company has granted the underwriters an option to purchase up to an additional 300,000 Common Shares, for a period of 30 days from the date of the final prospectus, to cover over-allotments, if any. The Common Shares are expected to begin trading on the NYSE...

BrilliA Inc Announces Pricing of Initial Public Offering

Written by Customer Service on November 27, 2024. Posted in Public Companies.

SINGAPORE, Nov. 26, 2024 (GLOBE NEWSWIRE) — BrilliA Inc (“BRIA” or “the Company”) today announced the pricing of its initial public offering of an aggregate of 2,500,000 shares of its Class A Ordinary Shares (“the Offering”), all of which are being offered by BRIA at a public offering price of $4.00 per share. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 375,000 shares of its Class A Ordinary Shares at the initial public offering price (“the Overallotment”), less underwriting discounts and commissions. The gross proceeds to BRIA from the Offering (assuming that the Overallotment is not exercised), before deducting underwriting discounts and commissions and estimated offering expenses payable by BRIA, is expected to be approximately $10,000,000. The shares are expected to...

Peptide Synthesis Market to Witness 13.0% CAGR by 2031 | SkyQuest Technology

Written by Customer Service on November 27, 2024. Posted in Mergers And Acquisitions.

Demand for peptide synthesis has increased significantly in the past decade and the approval of peptide-based diagnosis therapy solution has witnessed a spike post pandemic. Westford, USA, Nov. 26, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Peptide Synthesis Market Size will attain the value of USD 1861.20 Million by 2031, with a CAGR of 13.0% during the forecast period (2024-2031). Imaging technology demand is growing substantially for accurate diagnosis of chronic diseases. The use of biosensors and biomarkers for invasive and non-invasive diagnostics is also very common. Peptide based biosensors and biomarkers are experiencing huge demand growth fueling the peptide synthesis industry. Health care costs are rising sharply in developed countries of North America and Europe. Personalized medicine is growing due to rising healthcare...

JOYY Reports Third Quarter 2024 Unaudited Financial Results

Written by Customer Service on November 27, 2024. Posted in Earnings Releases And Operating Results.

SINGAPORE, Nov. 27, 2024 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: YY) (“JOYY” or the “Company”), a global technology company, today announced its unaudited financial results for the third quarter of 2024. Third Quarter 2024 Financial Highlights1Net revenues were US$558.7 million, compared to US$567.1 million in the corresponding period of 2023. Net income attributable to controlling interest of JOYY2 was US$60.6 million, compared to US$72.9 million in the corresponding period of 2023. Non-GAAP net income attributable to controlling interest and common shareholders of JOYY3 was US$61.2 million, compared to US$81.2 million in the corresponding period of 2023.Third Quarter 2024 Operational HighlightsAverage mobile MAUs of Bigo Live was 36.5 million, compared to 40.3 million in the corresponding period of 2023. Average mobile MAUs...

Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology

Written by Customer Service on November 27, 2024. Posted in Mergers And Acquisitions.

Personalized medicines amalgams medicine with genetic technology to facilitate specific treatment unique to each patient. The demand for personalized medicines is significant for diagnosis and treatment of cancer. Westford, USA, Nov. 26, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global personalized medicines market size will reach a value of USD 1352.81 Billion by 2031, with a CAGR of 11.40% during the forecast period (2024-2031). The personalized medicines market is majorly influenced by the growing demand for innovative therapies because of the increasing global prevalence of diseases such as cancer. Furthermore, it is expected that the expansion of the personalized medicines market would benefit from a number of partnerships between researchers and industry participants. Numerous businesses are adopting this strategy...

Fountain Asset Corp. Announces Its Financial Results for the Quarter Ended September 30, 2024

Written by Customer Service on November 27, 2024. Posted in Earnings Releases And Operating Results.

TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) — Fountain Asset Corp. (TSXV:FA) (“Fountain” or the “Company”) would like to announce its financial results for the three and nine months ended September 30, 2024 (“Q3/24”). Highlights from three months ended September 30, 2024:NAV of $5.03 million ($0.08/share) at September 30, 2024 compared to $5.73 million ($0.09/share) at June 30, 2024, representing a 11% decrease on a quarter over quarter per share basis. NAV is calculated as the value of total assets less the value of total liabilities; Net comprehensive losses of $0.71 million compared to net comprehensive losses of $0.75 million for the quarter ended September 30, 2023 (“Q3/23”); Total losses from investment activity was $0.43 million compared to losses of $0.59 million for Q3/23; Net realized gains on the sale of portfolio investments...

Legible Announces Cancellation of $0.14 Private Placement Unit Offering

Written by Customer Service on November 26, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 26, 2024 (GLOBE NEWSWIRE) — Legible Inc. (CSE: READ) (OTCQB: LEBGF) (FSE: D0T) (“Legible” or “the Company”), a leading platform and innovator in digital literature, announces the cancellation of its previously announced October 24, 2024 Private Placement Unit Offering (“the Offering”) comprised of one common share at $0.14 (“Common Share”) and one whole Common Share purchase warrant entitling the holder to acquire one additional Common Share at a price of $0.14 (“Units”). See the Company’s Press Release dated October 24, 2024, for further details. The cancellation of the Offering is due to the investor who signed a subscription agreement for 11,500,000 Units failing to wire the Company the subscription amount of $1,610,000 after confirming multiple times, in writing, that the $1,610,000 would be...

NorthWest Copper Announces Appointment of Paul Olmsted as CEO

Written by Customer Service on November 26, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 26, 2024 (GLOBE NEWSWIRE) — NorthWest Copper (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce the appointment of Paul Olmsted as Chief Executive Officer and a member of the Board of Directors, effective immediately. Mr. Olmsted brings over 30 years of experience in the mining industry, with a proven track record in project evaluation, development, financing and strategic leadership. Prior to joining NorthWest, from 2016 to 2023, Mr. Olmsted was the Chief Financial Officer of Superior Gold Inc., actively involved in the acquisition of an intermediate gold producer, followed by an initial public offering and ultimately leading the company through a business combination sale in 2023. Before Superior Gold, Mr. Olmsted was the Senior Vice President, Corporate Development of IAMGOLD...

NOVONIX Announces December Investor Events

Written by Customer Service on November 26, 2024. Posted in Public Companies.

BRISBANE, Australia, Nov. 26, 2024 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that the company is scheduled to host and participate in the following upcoming investor events in December 2024:NOVONIX will host an investor presentation by Dr. Chris Burns, CEO, and site tour at its Lookout Valley and Riverside facilities in Chattanooga, TN on December 5ᵗʰ. Due to limited capacity, in-person attendance is by invitation only. Investor questions may be submitted prior to the event at ir@novonixgroup.com. A replay of the presentation will be available on the NOVONIX Investor Relations website following the presentation. Jefferies Battery Storage & Materials Virtual Conference with Dr. Chris Burns to be held on December 13ᵗʰ at 1:40...

Immutable Holdings Announces Arrangements to Address Potential Mailing Delays for 2024 AGM Materials Resulting From Canada Post Strike

Written by Customer Service on November 26, 2024. Posted in Public Companies.

TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) — Immutable Holdings Inc. (CBOE: HOLD; OTC: IHLDF) (“Immutable Holdings” or the “Corporation”), a publicly-traded blockchain holding company, will hold its upcoming annual general meeting of shareholders on Friday, December 20, 2024 (the “Meeting”). Due to the ongoing national strike commenced by the Canadian Union of Postal Workers on November 15, 2024 (the “Strike”), Canada Post’s operations have shut down and the physical delivery of the materials for the Meeting (the “Materials”) may be delayed. In order to facilitate the delivery of the Corporation’s management information circular and related materials for the Meeting in the event that the Strike or similar or related events prevent, delay or otherwise interrupt delivery of the Materials, emails providing a proxy with the voting...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals